NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,550,428 | +21.3% | 374,004 | +33.4% | 0.03% | +25.0% |
| Q2 2023 | $13,646,587 | -15.7% | 280,448 | -3.8% | 0.02% | -20.0% |
| Q1 2023 | $16,190,982 | +174.6% | 291,626 | +98.7% | 0.03% | +130.8% |
| Q4 2022 | $5,895,562 | -20.7% | 146,783 | -13.5% | 0.01% | -23.5% |
| Q3 2022 | $7,436,000 | +7.3% | 169,690 | -14.0% | 0.02% | +13.3% |
| Q2 2022 | $6,932,000 | -27.4% | 197,329 | -16.6% | 0.02% | -21.1% |
| Q1 2022 | $9,544,000 | -40.4% | 236,518 | +37.8% | 0.02% | -36.7% |
| Q4 2021 | $16,007,000 | -0.4% | 171,640 | +18.7% | 0.03% | -11.8% |
| Q3 2021 | $16,068,000 | +16.5% | 144,586 | +19.1% | 0.03% | +9.7% |
| Q2 2021 | $13,793,000 | +126.7% | 121,401 | +101.7% | 0.03% | +106.7% |
| Q1 2021 | $6,084,000 | -24.6% | 60,179 | -25.8% | 0.02% | -28.6% |
| Q4 2020 | $8,072,000 | +26.1% | 81,100 | -8.5% | 0.02% | +10.5% |
| Q3 2020 | $6,402,000 | +43.8% | 88,661 | -0.7% | 0.02% | +35.7% |
| Q2 2020 | $4,451,000 | +194.6% | 89,268 | +76.4% | 0.01% | +133.3% |
| Q1 2020 | $1,511,000 | +100.1% | 50,600 | +125.8% | 0.01% | +200.0% |
| Q4 2019 | $755,000 | -21.1% | 22,413 | -23.1% | 0.00% | 0.0% |
| Q3 2019 | $957,000 | +362.3% | 29,164 | +190.5% | 0.00% | +100.0% |
| Q1 2019 | $207,000 | +5075.0% | 10,039 | +6335.3% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -99.6% | 156 | -99.7% | 0.00% | -100.0% |
| Q2 2018 | $928,000 | +436.4% | 49,293 | +216.1% | 0.00% | +200.0% |
| Q3 2016 | $173,000 | – | 15,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |